Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Charles E. Argoff, MD, Professor of Neurology and Director of The Comprehensive Pain Center at the Albany Medical Center, reviews certain decision effects using the topical medication versus…
Charles E. Argoff, MD, Professor of Neurology and Director of The Comprehensive Pain Center at the Albany Medical Center, speaks of the newly established guidelines for pharmacologic management…
Charles E. Argoff, MD, Professor of Neurology and Director of The Comprehensive Pain Center at the Albany Medical Center, speaks on different treatment options when dealing with pain.…
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the diagnosis and…
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the criteria for…
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the criteria for…
NEW YORK (Reuters Health) – For children and very lean adults who use a 5 mm insulin needle, angling the injection into a pinched skin fold reduces pain…
NEW YORK (Reuters Health) – Patients with localized prostate cancer can be treated successfully with high-intensity focused ultrasound (HIFU), with results comparable to those expected with external-beam radiation…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer who have not had a recurrence for 5 years after resection may not yet be free and clear.…
NEW YORK (Reuters Health) – Updated guidelines issued by the American Society of Clinical Oncology (ASCO) recommend that postmenopausal women with hormone receptor-positive breast cancer should receive aromatase…
